Venrock

AirSpeed makes it easy to copy Emails, Contacts and Appointments from Google (Gmail and Google Apps) to Salesforce. FREE 14-day trial. No credit card required. - Move emails, contacts and appointments from Google to Salesforce in a single click. - Design lets you continue using Gmail side bar plug-ins you love, like Rapportive - Team Edition lets Salesforce administrators centrally manage users and billing. Works with Chrome, Firefox and Safari, and all editions of Salesforce. Contact us for Internet Explorer availability.

Dev-first, fully-extensible managed Postgres.

Dgraph Labs, Inc. specializes in developing and operating a graph database designed for efficient real-time data retrieval. Founded in 2016 and based in San Francisco, the company offers a fully-managed, serverless solution called Slash Enterprise, which is tailored for enterprises handling terabytes of data across various cloud platforms. Dgraph's database is open source, horizontally scalable, and distributed, providing features such as ACID transactions and consistent replication to ensure high performance and low latency. Its architecture optimizes data arrangement on disk, enhancing query performance and throughput for diverse applications, including social graphs, recommendation engines, semantic search, and fraud detection. With support for GraphQL-like syntax and responsive output formats, Dgraph caters to the needs of both small startups and large enterprises, enabling them to manage and visualize extensive structured datasets efficiently.

Meltano is an open-source DataOps platform that integrates various leading open-source tools for managing the data lifecycle. It incorporates the Singer standard for data integration, featuring a library of over 200 connectors, as well as tools like dbt for data transformation, Airflow for orchestration, and plans to include Superset for data visualization. Meltano aims to simplify the processes of configuration, deployment, and monitoring while allowing data teams to adopt practices such as version control and continuous integration/continuous deployment. The platform collaborates with a community of over 1,200 professionals from startups, global enterprises, and consultancies to advance data infrastructure. Thousands of active projects utilizing Meltano are presently in operation across various organizations, demonstrating its practical application and adaptability in the data management landscape.

Developer of genetic medicines intended to treat cancer and other immune diseases. The company's medicines provide elegant cutting-edge in vivo gene delivery technology that uses potent lentiviral vector-like particles to precisely deliver in vivo genetic cargo to the desired target tissue, enabling physicians to get a pipeline of drugs for solid tumors and hematologic cancers and other immune diseases.

Vanilla is an estate planning platform designed to assist advisors in enhancing their relationships with clients and prospects without requiring specialized expertise. The platform addresses inefficiencies in document preparation and aims to improve both advisors' and clients' understanding of estate matters. By simplifying the complexities associated with estate planning and post-death processes, Vanilla enables advisors to identify opportunities for adding value, particularly for those clients facing estate tax considerations. This innovative approach empowers advisors to better serve their clients and unlock new value within their practice.

Quiq, Inc. is a customer service messaging management software company that facilitates communication between customers and businesses. Founded in 2015 and headquartered in Bozeman, Montana, Quiq enables customers to engage with companies through various messaging platforms, including SMS/text messaging, Facebook Messenger, and web chat. The company's offerings include Quiq IQ, which allows for the creation and deployment of automated bots for web chat and messaging channels. Quiq's messaging platform can be utilized as a standalone customer service channel or integrated with popular customer relationship management systems such as Oracle, Zendesk, and Salesforce. Originally known as Centricient Inc., the company rebranded to Quiq, Inc. in March 2017.

Astronomer, Inc., founded in 2014 and based in Cincinnati, Ohio, provides a managed platform for Apache Airflow, catering specifically to data engineers. The company focuses on enabling organizations to harness the capabilities of Apache Airflow through its flagship offering, Astronomer Cloud, which is recognized as a leading Airflow-as-a-Service solution. Astronomer is dedicated to enhancing standards of scale, performance, and reliability for enterprise-level data orchestration. Its platform encompasses a comprehensive suite of products and services that facilitate the deployment, management, and scaling of data pipelines. This includes features for isolated resource allocation, user access, and account management, allowing data engineers, scientists, and analysts to efficiently build, run, and monitor pipelines-as-code for effective business analytics.

Ocelot Bio brings new treatment options to patients with severe liver disease. The company was founded in 2020 and is headquartered in San Diego, California.

RefleXion Medical Inc. specializes in developing a biologically-guided radiotherapy system aimed at transforming cancer treatment. The company’s innovative technology allows tumors to continuously signal their location during therapy, facilitating the simultaneous treatment of multiple tumors, particularly in cases of metastasis. The RefleXion X1 machine is currently cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT). At the core of RefleXion's approach is the integration of positron-emission tomography (PET) imaging, which enables real-time tumor tracking and dose adaptation based on the biological characteristics of the tumors. This advancement in radiotherapy promises to enhance precision in cancer treatment, offering a potential paradigm shift in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic collaborations, including partnerships with Telix Pharmaceuticals and HealthMyne.

SmithRx is a pharmacy benefit manager based in San Francisco, California, that specializes in creating custom pharmacy benefit plans for companies to support their employees. Founded in 2016, the company employs a modern technology platform to enhance flexibility, efficiency, and customer satisfaction. SmithRx offers a cost-competitive pass-through model, a unified technology platform, and high-quality service guarantees related to drug costs and rebates. The firm’s in-house team comprises professionals with extensive experience from various healthcare companies and technology firms. Front-line clinicians play a key role in executing plans and providing member support. By leveraging technology and data analytics, SmithRx aims to redefine the pharmacy benefit landscape with a focus on precision and effectiveness.

Astrix Security provides a cloud-based access management solution specifically designed for third-party app integrations. As organizations increasingly rely on app-to-app connectivity, the potential for security vulnerabilities in their systems grows. Astrix's platform offers features for visibility, risk assessment, and automated remediation, allowing security teams to identify and address issues such as redundant, misconfigured, or malicious third-party access to critical systems. With its agentless, one-click deployment, Astrix enables organizations to manage security and compliance effectively while maximizing the benefits of automation and integrations, thereby mitigating the risks associated with service supply chain attacks.

Developer of a data engineering software designed for serverless streaming data. The company's platform allows applications and data engineers to build complex data pipelines to quickly connect to existing messaging, storage, and database systems, enabling users to collect, process, and deliver data to offline and online systems quickly.

Zero Networks Inc. is a company based in Tel Aviv, Israel, that specializes in cloud-based network security software. Founded in 2019, it focuses on automating the creation and enforcement of network access rules across entire networks. The company's technology intelligently learns how users and machines communicate, allowing for customized access control. It incorporates a two-factor authentication mechanism for users' mobile phones to ensure that legitimate connections, even if unusual, remain unaffected. Notably, Zero Networks eliminates the need for agents to be deployed and avoids complex policy configurations, providing straightforward and robust security for all users and machines within a network.

3Box Inc., founded in 2018 and based in New York, provides innovative tools for Ethereum users and developers. Its flagship offering, 3box.io, is a social profiles application that enables users to create and manage their online identities within decentralized applications (dApps). The company also offers 3box.js, an API designed for web3 developers to facilitate user onboarding and data management for profiles. Additionally, the 3box-dapp allows users to sign in to various dApps, interact socially, build reputations, and securely store their data. With a focus on simplicity, security, and privacy, 3Box aims to create a more trustworthy environment for applications that manage user data.

Atom Computing Inc. is a company based in Berkeley, California, that focuses on manufacturing scalable quantum computers utilizing individual atoms. Founded in 2018, the company harnesses the quantum mechanical properties of atoms to process information and address complex problems that traditional computers cannot solve. Atom Computing's technology allows for the optical control, scaling, and stabilization of these atoms, facilitating efficient quantum calculations in various fields, including drug design, computational chemistry, and general computing. Through its innovative approach, Atom Computing aims to advance the development of quantum technology and expand its applications across multiple industries.

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. Mythic Therapeutics was founded in 2017 and is headquartered in Waltham, MA, USA.

Suki AI, Inc. is a technology company that develops an AI-powered voice assistant specifically designed for healthcare professionals. The software, known as Suki, assists doctors by streamlining administrative tasks such as dictating notes, storing electronic health records, and retrieving patient data. It uses advanced natural language processing and machine learning to enhance accuracy and efficiency, allowing healthcare providers to distill conversations with patients into actionable plans, order prescriptions, and manage clinical documentation more effectively. Founded in 2017 and based in Redwood City, California, Suki aims to alleviate the administrative burden on clinicians, enabling them to focus more on patient care. The company was previously known as Robin AI, Inc. before rebranding in April 2018.

Skyryse, Inc. is an air mobility company founded in 2016 and headquartered in El Segundo, California. The company specializes in developing flight hardware and software, notably its operating system, FlightOS. This innovative system provides a common interface for pilots, allowing them to operate various types of aircraft, including helicopters and fixed-wing planes, with the same controls. FlightOS aims to enhance flight safety and streamline piloting by significantly reducing pilot fatigue and complexity, making it accessible for pilots to operate different aircraft configurations after minimal training. Skyryse serves various sectors, including emergency services, public transport, and urban planning, positioning itself as a leader in advancing general aviation technology.

Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The platform enables users to select and enroll in various affordable health coverage options, including dental, vision, and prescription insurance plans. Stride Health simplifies the process of finding suitable health insurance by providing personalized recommendations and tax deduction support, thereby helping customers maximize their take-home pay. The company, originally known as Covered, Inc., rebranded to Stride Health in March 2013 and has since been based in San Francisco, California. Through its services, Stride Health aims to make healthcare accessible and manageable for its users.

Rebellion Defense, Inc. is a software company founded in 2019, headquartered in Washington, D.C., with additional offices in Seattle and London. It specializes in developing artificial intelligence and machine learning software products designed to support national defense missions for the United States, the United Kingdom, and their allies. The company's solutions focus on analyzing, securing, and transporting data relevant to national security and defense, providing innovative tools to enhance operational capabilities in this critical sector.

Vanilla is an estate planning platform designed to assist advisors in enhancing their relationships with clients and prospects without requiring specialized expertise. The platform addresses inefficiencies in document preparation and aims to improve both advisors' and clients' understanding of estate matters. By simplifying the complexities associated with estate planning and post-death processes, Vanilla enables advisors to identify opportunities for adding value, particularly for those clients facing estate tax considerations. This innovative approach empowers advisors to better serve their clients and unlock new value within their practice.

Interos Inc. develops a supply chain assurance and risk management platform that enables businesses to identify and analyze risks affecting their supply chains. The platform employs advanced technologies such as machine learning and natural language understanding to assess financial, operational, governance, geographic, and cyber risks related to suppliers. By aggregating and analyzing large datasets, Interos provides predictive and prescriptive insights that help organizations monitor and enhance their resilience against potential disruptions. Its offerings include Eco-system Maps, Supplier Risk Assessments, Scoring, and Continuous Monitoring, catering to various sectors including finance, consumer products, defense, and technology. Founded in 2005, Interos is based in Arlington, Virginia, with an additional office in Menlo Park, California.

Atom Computing Inc. is a company based in Berkeley, California, that focuses on manufacturing scalable quantum computers utilizing individual atoms. Founded in 2018, the company harnesses the quantum mechanical properties of atoms to process information and address complex problems that traditional computers cannot solve. Atom Computing's technology allows for the optical control, scaling, and stabilization of these atoms, facilitating efficient quantum calculations in various fields, including drug design, computational chemistry, and general computing. Through its innovative approach, Atom Computing aims to advance the development of quantum technology and expand its applications across multiple industries.

AirSpeed makes it easy to copy Emails, Contacts and Appointments from Google (Gmail and Google Apps) to Salesforce. FREE 14-day trial. No credit card required. - Move emails, contacts and appointments from Google to Salesforce in a single click. - Design lets you continue using Gmail side bar plug-ins you love, like Rapportive - Team Edition lets Salesforce administrators centrally manage users and billing. Works with Chrome, Firefox and Safari, and all editions of Salesforce. Contact us for Internet Explorer availability.

Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company provides a disruptive DNA sequencing technology and a sequencing platform, such as surface chemistry, sequencing chemistry, detection, and data analysis. The company was incorporated in 2017 and is based in San Diego, California.

Altruist is a fintech company that develops a commission-free digital investment platform. The platform is designed to help independent financial advisors grow faster, cut costs, eliminate paperwork, and delight their clients. The company was founded in 2018 and is headquartered in Venice, California.

CMDTY Inc. specializes in providing a software platform designed for commodity tracking and logistics companies. Founded in 2019 and headquartered in Brooklyn, New York, CMDTY develops solutions that enhance the management of operations and logistics within the physical commodity supply chain. The platform addresses inefficiencies by facilitating real-time interactions between buyers and producers, thereby improving the delivery of advertising and enhancing supply chain resilience and sustainability. Through its digital tools, CMDTY aims to streamline processes related to buying, selling, transporting, and financing commodities, ultimately fostering a more collaborative and effective supply chain environment.

Astranis Space Technologies Corp. is a San Francisco-based company that designs and manufactures small telecommunications satellites aimed at enhancing Internet connectivity. Founded in 2015, Astranis specializes in its MicroGEO technology for geostationary orbit, enabling efficient data transmission to specific terrestrial locations. The company's primary mission is to bridge the digital divide by providing high-speed, reliable internet access to underserved regions at a significantly lower cost than traditional methods. By focusing on connecting the four billion people worldwide who currently lack internet access, Astranis aims to empower governments and businesses to expand internet connectivity and facilitate communication across the globe.

TAE Technologies is leveraging proprietary science and engineering to tackle the world’s biggest challenges. Their core mission is to create a new source of clean energy – one that’s powered by nature’s own processes and produces no harmful byproducts. Their groundbreaking work has led to industry-wide advances in accelerator and plasma physics, and acted as a catalyst for adjacent innovations based on their results. With 20 years of focused research, TAE Technologies is on a purposeful path to commercial fusion energy and pioneering sustainable solutions for a better tomorrow.

Auditoria.AI, Inc., founded in 2019 and located in Santa Clara, California, specializes in AI-driven automation solutions tailored for finance teams. The company focuses on enhancing enterprise accounting and audit processes through its flagship product, Auditoria SmartFlow Skills. This innovative offering utilizes natural language processing, artificial intelligence, and machine learning to streamline finance back office operations, eliminate repetitive tasks, and provide real-time predictive analytics. By integrating these technologies, Auditoria.AI aims to improve efficiency and accuracy for finance and accounting teams, thereby transforming traditional business practices in the financial sector.

Dapper Labs Inc., based in Vancouver, Canada, is a developer of blockchain-based video games and digital collectibles. Founded in 2018, the company is known for its consumer-focused Flow blockchain platform, which supports the creation and distribution of non-fungible tokens (NFTs) and other digital assets. Dapper Labs aims to enhance digital engagement by allowing fans to interact with their favorite brands in innovative ways. Through its platform, users can securely track ownership of unique digital items while also having the opportunity to create their own content. This approach not only entertains but also fosters a decentralized environment where value is placed on digital collectibles and user-generated creations.

Developer of a data engineering software designed for serverless streaming data. The company's platform allows applications and data engineers to build complex data pipelines to quickly connect to existing messaging, storage, and database systems, enabling users to collect, process, and deliver data to offline and online systems quickly.

Cyteir Therapeutics, Inc. focuses on developing innovative therapeutics that harness the biology of DNA repair to treat cancer and address autoimmune diseases through synthetic lethality. The company manufactures targeted therapeutics designed to induce the self-destruction of diseased cells by overwhelming them with DNA damage. Utilizing an integrated drug development platform, Cyteir aims to balance DNA damage and repair mechanisms to achieve therapeutic effects. Its diverse pipeline includes small molecule therapeutics intended for various applications, particularly in hematological malignancies, solid tumors, and chronic autoimmune disorders. Founded in 2012 and headquartered in Lexington, Massachusetts, Cyteir Therapeutics is committed to overcoming significant challenges in oncology, such as minimizing side effects, reducing therapy resistance, and promoting the self-destruction of cancerous cells.

Sitka, Inc. is a technology company that operates an online communication platform designed to connect patients with healthcare providers across various specialties, including endocrinology, neurology, orthopedics, pulmonology, and rheumatology. Founded in 2018 by experts in healthcare, the platform emphasizes the upskilling of primary care providers and aims to enhance the specialty care experience in the United States. Sitka facilitates personalized consultations, allowing patients to receive tailored advice and recommendations from board-certified specialists based on their medical conditions and diagnostic results. By streamlining communication and fostering patient inclusion, Sitka seeks to improve care delivery and ensure that all patients receive informed and effective treatment. The company is headquartered in Carmel, California, and has received backing from several prominent investors in the healthcare sector.

Altruist is a fintech company that develops a commission-free digital investment platform. The platform is designed to help independent financial advisors grow faster, cut costs, eliminate paperwork, and delight their clients. The company was founded in 2018 and is headquartered in Venice, California.

RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. The company specializes in developing tumor-targeted small molecule medicines that utilize radioisotopes, particularly focusing on alpha-emitting isotopes like Actinium-225 for the treatment of solid tumors. RayzeBio aims to improve cancer treatment outcomes by creating a robust pipeline of radiopharmaceuticals targeting validated oncology drug targets. Its portfolio includes multiple drug candidates at various stages of development, ranging from discovery to late-stage clinical programs, addressing significant market opportunities in the field of cancer therapeutics.

Luma, Inc. is a company that specializes in designing and developing technology for managing events. Founded in 2020 and headquartered in Santa Monica, California, Luma offers a platform that facilitates the organization of live virtual events. Its services include ticket sales, membership management, attendance tracking, and analytics, as well as tools for sending invitations and posting stories. The platform caters to professionals by providing them with the necessary tools to host virtual classes and live shows, thereby enhancing their ability to educate and connect with their communities.

Pharvaris B.V. is a clinical-stage company based in Leiden, the Netherlands, focused on the discovery and development of oral bradykinin B2 receptor antagonists for the treatment of hereditary angioedema (HAE) and other conditions linked to B2 receptor activity. Established in 2015, the company aims to provide new therapeutic options that eliminate the need for injections. Its lead drug candidate, PHA121, is a novel small-molecule antagonist currently undergoing Phase 1 clinical trials. Pharvaris benefits from the expertise of its co-founders, including an inventor of icatibant, which is a previously developed treatment for HAE. The company is dedicated to advancing alternatives to existing therapies, enhancing the quality of life for patients with HAE.

Mable operates an online wholesale platform designed for independent grocers and small businesses, facilitating the ordering and discovery of products. Based in Boston, Massachusetts, the platform allows retailers and distributors to easily find and purchase a diverse range of goods from various suppliers, including well-known brands like Black Dinah Chocolatiers and Crown Maple. Mable's technology streamlines wholesale ordering and marketing, enabling users to manage their inventory and product sourcing efficiently in one location. By integrating mobile ordering capabilities, Mable enhances accessibility for retailers and supports emerging brands in reaching their target market effectively.

Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company's microbial therapy leverages naturally occurring or engineered bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a wide range of human conditions, from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions.

Olema Oncology is a clinical-stage biopharmaceutical company dedicated to developing targeted therapies for women's cancers, particularly estrogen receptor (ER)-positive breast cancer. The company's lead candidate, OP-1250, is an ER antagonist and selective ER degrader currently undergoing Phase 1/2 clinical trials for the treatment of metastatic or locally advanced, ER-positive, and human epidermal growth factor receptor 2-negative breast cancer. Olema's research focuses on utilizing its expertise in endocrine-driven cancers and the molecular mechanisms of the ER to create more effective treatments that aim to improve patient outcomes. In addition to OP-1250, Olema is advancing another drug candidate, OP-3136, further enriching its pipeline. Established in 2006 and headquartered in San Francisco, California, Olema is committed to transforming the standard of care for women facing these challenging diagnoses.

Salsify is an e-commerce software startup based in Boston, Massachusetts, founded in 2012 by Jason Purcell, Jeremy Redburn, and Rob Gonzalez. The company provides brands with tools to manage and optimize their product information, inventory, and sales across various digital platforms. Its primary offering, Commerce Experience Management (CommerceXM), integrates Product Experience Management with commerce capabilities to facilitate sales through retailer and distributor channels, as well as marketplaces, social commerce, and direct-to-consumer sites. Salsify aims to empower brands to create engaging shopping experiences for consumers across all digital touchpoints. The company has received backing from notable investors, including Venrock, Matrix Partners, and Warburg Pincus.

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics. The company is pioneering a powerful protein engineering-focused approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Their technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. Mythic Therapeutics was founded in 2017 and is headquartered in Waltham, MA, USA.

Olema Oncology is a clinical-stage biopharmaceutical company dedicated to developing targeted therapies for women's cancers, particularly estrogen receptor (ER)-positive breast cancer. The company's lead candidate, OP-1250, is an ER antagonist and selective ER degrader currently undergoing Phase 1/2 clinical trials for the treatment of metastatic or locally advanced, ER-positive, and human epidermal growth factor receptor 2-negative breast cancer. Olema's research focuses on utilizing its expertise in endocrine-driven cancers and the molecular mechanisms of the ER to create more effective treatments that aim to improve patient outcomes. In addition to OP-1250, Olema is advancing another drug candidate, OP-3136, further enriching its pipeline. Established in 2006 and headquartered in San Francisco, California, Olema is committed to transforming the standard of care for women facing these challenging diagnoses.

VelosBio, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative antibody-drug conjugates (ADCs) to treat hematological cancers and solid tumors. The company specializes in therapies targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1), a cell-surface protein commonly found in various tumors but absent in normal tissues, making it a promising target for cancer treatment. Its lead product, VLS-101, is designed as a ROR1-directed ADC aimed at patients with both hematologic and solid tumor malignancies. Founded in 2017, VelosBio has demonstrated positive preclinical results for its ROR1-directed therapeutics, paving the way for potential use in monotherapy or in combination with other treatments across a wide range of cancers. As of late 2020, VelosBio operates as a subsidiary of Merck & Co., Inc.

CVRx, Inc. is a medical device company based in Minneapolis, Minnesota, that specializes in implantable technology for treating high blood pressure and heart failure. The company develops Barostim, a proprietary neuromodulation therapy that activates the body's natural reflexes to regulate blood pressure and address the progression of heart failure. This therapy is delivered through a long-lasting implant system that is tailored to meet individual patient needs. CVRx also manufactures the Rheos implantable pulse generator and associated components, which facilitate the delivery of activation energy to the carotid arteries. Founded in 2000, CVRx primarily serves patients and healthcare professionals in the United States and several European countries, focusing on minimally invasive solutions for cardiovascular diseases.

Astronomer, Inc., founded in 2014 and based in Cincinnati, Ohio, provides a managed platform for Apache Airflow, catering specifically to data engineers. The company focuses on enabling organizations to harness the capabilities of Apache Airflow through its flagship offering, Astronomer Cloud, which is recognized as a leading Airflow-as-a-Service solution. Astronomer is dedicated to enhancing standards of scale, performance, and reliability for enterprise-level data orchestration. Its platform encompasses a comprehensive suite of products and services that facilitate the deployment, management, and scaling of data pipelines. This includes features for isolated resource allocation, user access, and account management, allowing data engineers, scientists, and analysts to efficiently build, run, and monitor pipelines-as-code for effective business analytics.

Iris Medicine focuses its services in the pharmaceutical and healthcare industry. The company was founded in 2019 and based in Palo Alto, California.

RefleXion Medical Inc. specializes in developing a biologically-guided radiotherapy system aimed at transforming cancer treatment. The company’s innovative technology allows tumors to continuously signal their location during therapy, facilitating the simultaneous treatment of multiple tumors, particularly in cases of metastasis. The RefleXion X1 machine is currently cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT). At the core of RefleXion's approach is the integration of positron-emission tomography (PET) imaging, which enables real-time tumor tracking and dose adaptation based on the biological characteristics of the tumors. This advancement in radiotherapy promises to enhance precision in cancer treatment, offering a potential paradigm shift in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic collaborations, including partnerships with Telix Pharmaceuticals and HealthMyne.

ABL Space Systems is a company focused on designing and manufacturing low-cost rockets for the small satellite market. Founded in 2017 by former SpaceX engineers, the company is headquartered in El Segundo, California, where it operates facilities covering 30,000 square feet dedicated to research, development, and production. ABL's primary launch vehicle, the RS1, is designed to support various configurations for deploying small satellites, including multi-manifest and dedicated launches. The company's innovative approach features a simplified tank architecture and advanced propellant management systems, which aim to enhance the efficiency and routine nature of orbital launches. As a privately-owned entity, ABL is backed by a group of prominent private equity investors.

Interos Inc. develops a supply chain assurance and risk management platform that enables businesses to identify and analyze risks affecting their supply chains. The platform employs advanced technologies such as machine learning and natural language understanding to assess financial, operational, governance, geographic, and cyber risks related to suppliers. By aggregating and analyzing large datasets, Interos provides predictive and prescriptive insights that help organizations monitor and enhance their resilience against potential disruptions. Its offerings include Eco-system Maps, Supplier Risk Assessments, Scoring, and Continuous Monitoring, catering to various sectors including finance, consumer products, defense, and technology. Founded in 2005, Interos is based in Arlington, Virginia, with an additional office in Menlo Park, California.

Lyra Health, Inc. is a Burlingame, California-based company that operates a digital platform connecting employers with mental health care providers. Founded in 2015, Lyra Health aims to improve access to effective mental health care for employees by utilizing innovative matching technology. The platform enables members to find personalized care by connecting them to a curated network of therapists and coaches, facilitating live video therapy and offering digital self-care tools. Lyra Health assesses treatment outcomes using clinical measures, such as the PHQ-9 and GAD-7, to monitor symptom improvement for conditions like anxiety and depression. This approach has resulted in significantly higher engagement and better outcomes compared to traditional mental health plans. Through its services, Lyra Health helps employees navigate the mental health system, schedule appointments, and maintain support throughout their treatment journey.

Amunix Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing novel protein and peptide therapeutics for cancer treatment. The company specializes in creating prodrugs that utilize innovative platforms such as XTEN for half-life extension, XPAT for protease-activated T cell engagement, and ProTIA for immuno-oncology applications. Amunix aims to develop therapies that can effectively activate the immune system to target solid tumors, thereby improving patient outcomes. The company collaborates with various partners in the biotechnology and pharmaceutical sectors to leverage its proprietary technologies across multiple therapeutic areas. Founded in 2006 and headquartered in Mountain View, California, Amunix is committed to advancing breakthrough therapies to combat cancer.

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel treatments for patients with hematological and musculoskeletal disorders that have significant unmet medical needs. The company's lead product candidate, KER-050, targets low blood cell counts, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and myelofibrosis. Additionally, Keros is advancing KER-047, a small molecule therapeutic in Phase 1 clinical trials, aimed at treating anemia related to elevated hepcidin levels and fibrodysplasia ossificans progressiva. The company's third candidate, KER-012, focuses on disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, as well as pulmonary arterial hypertension. Founded in 2015 and based in Lexington, Massachusetts, Keros Therapeutics is recognized for its expertise in the role of the Transforming Growth Factor-Beta family of proteins, which regulate red blood cell and platelet production, along with muscle and bone maintenance.

Suki AI, Inc. is a technology company that develops an AI-powered voice assistant specifically designed for healthcare professionals. The software, known as Suki, assists doctors by streamlining administrative tasks such as dictating notes, storing electronic health records, and retrieving patient data. It uses advanced natural language processing and machine learning to enhance accuracy and efficiency, allowing healthcare providers to distill conversations with patients into actionable plans, order prescriptions, and manage clinical documentation more effectively. Founded in 2017 and based in Redwood City, California, Suki aims to alleviate the administrative burden on clinicians, enabling them to focus more on patient care. The company was previously known as Robin AI, Inc. before rebranding in April 2018.

Astranis Space Technologies Corp. is a San Francisco-based company that designs and manufactures small telecommunications satellites aimed at enhancing Internet connectivity. Founded in 2015, Astranis specializes in its MicroGEO technology for geostationary orbit, enabling efficient data transmission to specific terrestrial locations. The company's primary mission is to bridge the digital divide by providing high-speed, reliable internet access to underserved regions at a significantly lower cost than traditional methods. By focusing on connecting the four billion people worldwide who currently lack internet access, Astranis aims to empower governments and businesses to expand internet connectivity and facilitate communication across the globe.

Virta Health operates an online specialty medical clinic focused on reversing type 2 diabetes without the use of medications or surgery. Founded in 2014 and based in San Francisco, the company combines nutritional biochemistry, clinical expertise, data science, and digital tools to develop its treatment protocols. Through its continuous remote care platform, Virta provides medical and behavioral support to patients, resulting in significant health improvements. In clinical trials, 60% of participants achieved diabetes reversal within one year, and 94% of insulin users were able to reduce or eliminate their insulin usage. The benefits of Virta's treatment extend to other aspects of metabolic and cardiovascular health, demonstrating sustained improvements in blood pressure, inflammation, liver function, and body mass index (BMI).

Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company provides a disruptive DNA sequencing technology and a sequencing platform, such as surface chemistry, sequencing chemistry, detection, and data analysis. The company was incorporated in 2017 and is based in San Diego, California.

Kyruus, Inc. is a provider of web-based software solutions focused on optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010 and headquartered in Boston, Massachusetts, Kyruus offers a suite of analytically driven products designed to enhance the engagement, management, and performance of healthcare providers. Its solutions include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which provides administrators with tools to monitor and analyze physician performance. Additionally, the company offers Kyruus MDSeekyr for identifying high-value providers and Kyruus Insight Reports for evaluating physician network trends and performance. The ProviderMatch suite further aids hospitals in connecting patients with the most suitable providers, ensuring a seamless patient experience while aligning provider availability with patient demand. Through its proprietary data management platform, Kyruus leverages accurate data to facilitate effective appointments and enhance overall patient care.

Inscripta, Inc. is a gene editing technology company focused on developing advanced CRISPR enzymes, specifically MADzymes, for precision gene editing. Founded in 2015 and headquartered in Boulder, Colorado, with additional offices in Pleasanton and San Diego, Inscripta aims to revolutionize genome engineering through its innovative benchtop platform. This platform integrates an instrument, consumables, software, and assays to facilitate fully automated and scalable editing of single cells, enabling researchers to conduct massively parallel experiments with unprecedented efficiency. By offering tools that simplify the editing process and making its MAD7 CRISPR nuclease available for research, Inscripta seeks to empower scientists in overcoming existing technical and licensing barriers, fostering a new era of biological discovery.

Nightfall is a developer of an application that utilizes machine learning to identify and manage business-critical data, such as personally identifiable information (PII). The company's technology integrates seamlessly with various software-as-a-service (SaaS) platforms, APIs, and data infrastructures, ensuring comprehensive data classification and protection. Nightfall's system automatically classifies sensitive data to prevent oversight and establishes automated workflows for tasks such as quarantining, deleting, and alerting users about potential risks. This approach enables organizations to streamline their data management processes while enhancing their security measures.

Cyteir Therapeutics, Inc. focuses on developing innovative therapeutics that harness the biology of DNA repair to treat cancer and address autoimmune diseases through synthetic lethality. The company manufactures targeted therapeutics designed to induce the self-destruction of diseased cells by overwhelming them with DNA damage. Utilizing an integrated drug development platform, Cyteir aims to balance DNA damage and repair mechanisms to achieve therapeutic effects. Its diverse pipeline includes small molecule therapeutics intended for various applications, particularly in hematological malignancies, solid tumors, and chronic autoimmune disorders. Founded in 2012 and headquartered in Lexington, Massachusetts, Cyteir Therapeutics is committed to overcoming significant challenges in oncology, such as minimizing side effects, reducing therapy resistance, and promoting the self-destruction of cancerous cells.

Mable operates an online wholesale platform designed for independent grocers and small businesses, facilitating the ordering and discovery of products. Based in Boston, Massachusetts, the platform allows retailers and distributors to easily find and purchase a diverse range of goods from various suppliers, including well-known brands like Black Dinah Chocolatiers and Crown Maple. Mable's technology streamlines wholesale ordering and marketing, enabling users to manage their inventory and product sourcing efficiently in one location. By integrating mobile ordering capabilities, Mable enhances accessibility for retailers and supports emerging brands in reaching their target market effectively.

Percipient.ai is a provider of an artificial intelligence advanced analytics platform designed to provide solutions for Intelligence and U.S. National Security. The company's products offer geo-correlated multi-source intelligence using computer vision to accelerate understanding of unstructured data at speed and scale, providing its clients with human and machine teaming in time-sensitive missions and global business environments.

CMDTY Inc. specializes in providing a software platform designed for commodity tracking and logistics companies. Founded in 2019 and headquartered in Brooklyn, New York, CMDTY develops solutions that enhance the management of operations and logistics within the physical commodity supply chain. The platform addresses inefficiencies by facilitating real-time interactions between buyers and producers, thereby improving the delivery of advertising and enhancing supply chain resilience and sustainability. Through its digital tools, CMDTY aims to streamline processes related to buying, selling, transporting, and financing commodities, ultimately fostering a more collaborative and effective supply chain environment.

Simbe Robotics, Inc. is a San Francisco-based company founded in 2014 that specializes in autonomous robotic solutions for the retail industry. Its flagship product, Tally, automates the tedious tasks of auditing store shelves, such as identifying out-of-stock and low-stock items, locating misplaced products, and detecting pricing errors. The robot operates safely during normal store hours, allowing it to navigate aisles alongside shoppers and employees. By capturing real-time inventory data, Tally enables retail staff to enhance operational efficiency and improve inventory management, ultimately streamlining store performance and supporting informed decision-making.

Pharvaris B.V. is a clinical-stage company based in Leiden, the Netherlands, focused on the discovery and development of oral bradykinin B2 receptor antagonists for the treatment of hereditary angioedema (HAE) and other conditions linked to B2 receptor activity. Established in 2015, the company aims to provide new therapeutic options that eliminate the need for injections. Its lead drug candidate, PHA121, is a novel small-molecule antagonist currently undergoing Phase 1 clinical trials. Pharvaris benefits from the expertise of its co-founders, including an inventor of icatibant, which is a previously developed treatment for HAE. The company is dedicated to advancing alternatives to existing therapies, enhancing the quality of life for patients with HAE.

Numerated Growth Technologies, Inc. is a Boston-based company founded in 2015 that specializes in developing a real-time sales platform for business and retail banking. The company's digital lending and sales platform simplifies the process for businesses to access financial products from banks by enabling seamless digital applications, account openings, and lending experiences. Numerated enhances these services through rich data integrations, credit pre-screening, and core data analysis tools, which assist banks in executing more targeted sales and marketing campaigns. The platform is utilized by several prominent business banks, including Bremer Bank, Dollar Bank, and Eastern Bank, among others.

Altruist is a fintech company that develops a commission-free digital investment platform. The platform is designed to help independent financial advisors grow faster, cut costs, eliminate paperwork, and delight their clients. The company was founded in 2018 and is headquartered in Venice, California.

Dapper Labs Inc., based in Vancouver, Canada, is a developer of blockchain-based video games and digital collectibles. Founded in 2018, the company is known for its consumer-focused Flow blockchain platform, which supports the creation and distribution of non-fungible tokens (NFTs) and other digital assets. Dapper Labs aims to enhance digital engagement by allowing fans to interact with their favorite brands in innovative ways. Through its platform, users can securely track ownership of unique digital items while also having the opportunity to create their own content. This approach not only entertains but also fosters a decentralized environment where value is placed on digital collectibles and user-generated creations.

Quiq, Inc. is a customer service messaging management software company that facilitates communication between customers and businesses. Founded in 2015 and headquartered in Bozeman, Montana, Quiq enables customers to engage with companies through various messaging platforms, including SMS/text messaging, Facebook Messenger, and web chat. The company's offerings include Quiq IQ, which allows for the creation and deployment of automated bots for web chat and messaging channels. Quiq's messaging platform can be utilized as a standalone customer service channel or integrated with popular customer relationship management systems such as Oracle, Zendesk, and Salesforce. Originally known as Centricient Inc., the company rebranded to Quiq, Inc. in March 2017.

Encoded Therapeutics, Inc. is a biotechnology company focused on developing precision gene therapies for severe genetic disorders. The company's innovative platform identifies sequences within the human genome that regulate gene expression through advanced screening and computational methods. Its therapy pipeline targets a variety of genetic and acquired disorders across multiple disease pathways, including neurocircuitry, liver and metabolic disorders, neurodegeneration, and cardiovascular diseases. Founded in 2014 and headquartered in South San Francisco, California, Encoded Therapeutics aims to enhance treatment options available to medical practitioners, ultimately improving patient outcomes and quality of life.

3Box Inc., founded in 2018 and based in New York, provides innovative tools for Ethereum users and developers. Its flagship offering, 3box.io, is a social profiles application that enables users to create and manage their online identities within decentralized applications (dApps). The company also offers 3box.js, an API designed for web3 developers to facilitate user onboarding and data management for profiles. Additionally, the 3box-dapp allows users to sign in to various dApps, interact socially, build reputations, and securely store their data. With a focus on simplicity, security, and privacy, 3Box aims to create a more trustworthy environment for applications that manage user data.

Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company provides a disruptive DNA sequencing technology and a sequencing platform, such as surface chemistry, sequencing chemistry, detection, and data analysis. The company was incorporated in 2017 and is based in San Diego, California.

Dstillery, Inc. is a digital intelligence platform that specializes in custom audience solutions for brands and their media partners. Founded in 2008 and based in New York, the company offers a range of marketing solutions designed to enhance brand awareness, consideration, and customer retention. Dstillery's premier product, Custom AI Audiences, utilizes tailored artificial intelligence models to deliver accurate and scalable audience targeting. The platform integrates mobile location insights with desktop behaviors, optimizing marketing efforts across various channels, including mobile, desktop, and video. Dstillery also provides geospatial insights through its Dscover Maps tool, allowing brands to analyze market composition by geography. The company serves a diverse clientele across multiple sectors, including retail, finance, and technology, helping them leverage customer data to drive revenue growth and improve audience engagement.

Concentric Analgesics, Inc. is a biopharmaceutical company dedicated to developing non-opioid therapeutics aimed at managing acute and chronic pain. Founded in 2014 and headquartered in San Francisco, California, the company is focused on addressing significant medical needs through innovative pain management solutions. Its development pipeline includes CA-008, an injectable prodrug of capsaicin designed for acute post-surgical pain, and CA-051, which is intended for epidural administration to treat refractory pain associated with cancer or amputation. Additionally, Concentric Analgesics is working on an injection product to alleviate chronic pain linked to moderate to severe osteoarthritis. By targeting pain at its source with limited systemic exposure, the company's therapies aim to simplify patient care and enhance treatment outcomes.

Biolux Research develops and distributes innovative orthodontic products aimed at improving dental treatment outcomes. The company is known for its flagship devices, OrthoPulse and OsseoPulse. OrthoPulse utilizes low levels of light energy to stimulate the bone surrounding teeth, which may facilitate faster tooth movement and potentially shorten the duration of orthodontic treatments such as braces or clear aligners. OsseoPulse focuses on bone regeneration, enhancing dental procedures. Founded in 2003, Biolux Research is headquartered in Vancouver, Canada, and is dedicated to making orthodontic treatments less invasive and more comfortable through advanced technologies.

6sense Insights Inc. is a predictive intelligence platform that aids B2B marketing and sales leaders in identifying potential prospects and understanding market dynamics through data-driven insights. Established in 2013 and headquartered in San Francisco, California, with additional offices in Texas and India, 6sense integrates various sources of time-sensitive activity, static data, and external information to offer a unified account engagement platform. This platform leverages artificial intelligence, big data, and machine learning to provide revenue teams with deep insights into buyer behavior, allowing them to prioritize accounts, engage resistant buying teams, and implement personalized multi-channel campaigns. By uncovering anonymous demand and optimizing data fragmentation, 6sense enables its users to predictably grow revenue and improve sales conversions.

MakeSchool is an educational organization that offers a degree program designed to foster a direct connection between education and employment for high school graduates. It operates both online and offline platforms, providing essential services such as instructional support, curriculum development, and admissions assistance. By partnering with established universities, MakeSchool aims to create innovative college programs that remain relevant in today's economy. The organization focuses on enhancing accessibility to higher education for students from diverse backgrounds, ultimately preparing them for careers as software developers or startup founders.

Inscripta, Inc. is a gene editing technology company focused on developing advanced CRISPR enzymes, specifically MADzymes, for precision gene editing. Founded in 2015 and headquartered in Boulder, Colorado, with additional offices in Pleasanton and San Diego, Inscripta aims to revolutionize genome engineering through its innovative benchtop platform. This platform integrates an instrument, consumables, software, and assays to facilitate fully automated and scalable editing of single cells, enabling researchers to conduct massively parallel experiments with unprecedented efficiency. By offering tools that simplify the editing process and making its MAD7 CRISPR nuclease available for research, Inscripta seeks to empower scientists in overcoming existing technical and licensing barriers, fostering a new era of biological discovery.

Inscripta, Inc. is a gene editing technology company focused on developing advanced CRISPR enzymes, specifically MADzymes, for precision gene editing. Founded in 2015 and headquartered in Boulder, Colorado, with additional offices in Pleasanton and San Diego, Inscripta aims to revolutionize genome engineering through its innovative benchtop platform. This platform integrates an instrument, consumables, software, and assays to facilitate fully automated and scalable editing of single cells, enabling researchers to conduct massively parallel experiments with unprecedented efficiency. By offering tools that simplify the editing process and making its MAD7 CRISPR nuclease available for research, Inscripta seeks to empower scientists in overcoming existing technical and licensing barriers, fostering a new era of biological discovery.

Socrates AI brings deep expertise in Artificial Intelligence, Natural Language Processing and Human Resources Applications to solve the enterprise's biggest challenges in employee experience, IT security and software engagement.

Running Tide is a global ocean health company focused on developing innovative aquaculture techniques to enhance both flavor and nutritional value while addressing climate challenges. By leveraging scientific expertise, the company aims to produce sustainable, low-carbon protein sources. Running Tide employs nature-based interventions to remove carbon from the atmosphere and combat ocean acidification. Its approach involves the design and development of integrated software and hardware systems that utilize photosynthesis, ocean currents, and gravity to sequester carbon in the deep ocean. Through the analysis of ocean data, Running Tide seeks to optimize the use of the Earth's vast marine environments, thereby improving ocean health and amplifying the natural restorative capabilities of the ocean.

Rebellion Defense, Inc. is a software company founded in 2019, headquartered in Washington, D.C., with additional offices in Seattle and London. It specializes in developing artificial intelligence and machine learning software products designed to support national defense missions for the United States, the United Kingdom, and their allies. The company's solutions focus on analyzing, securing, and transporting data relevant to national security and defense, providing innovative tools to enhance operational capabilities in this critical sector.

Inscripta, Inc. is a gene editing technology company focused on developing advanced CRISPR enzymes, specifically MADzymes, for precision gene editing. Founded in 2015 and headquartered in Boulder, Colorado, with additional offices in Pleasanton and San Diego, Inscripta aims to revolutionize genome engineering through its innovative benchtop platform. This platform integrates an instrument, consumables, software, and assays to facilitate fully automated and scalable editing of single cells, enabling researchers to conduct massively parallel experiments with unprecedented efficiency. By offering tools that simplify the editing process and making its MAD7 CRISPR nuclease available for research, Inscripta seeks to empower scientists in overcoming existing technical and licensing barriers, fostering a new era of biological discovery.

Misty Robotics, Inc. is a Boulder, Colorado-based company that specializes in the development and manufacturing of personal robots for home and office environments. Founded in 2017 as a spinoff of Sphero, the company aims to integrate robots into everyday life, allowing them to perform helpful tasks, enhance safety, and engage with humans in an entertaining manner. The flagship product, the Misty II platform, is designed for use by software developers, educators, and researchers, facilitating the deployment of robotics in various sectors. By making personal robots accessible and user-friendly, Misty Robotics envisions a future where these machines are perceived as companions and helpers, enriching the lives of their users. The company sells its products online, focusing on accelerating the adoption of robotics technology in both domestic and professional settings.

Skyryse, Inc. is an air mobility company founded in 2016 and headquartered in El Segundo, California. The company specializes in developing flight hardware and software, notably its operating system, FlightOS. This innovative system provides a common interface for pilots, allowing them to operate various types of aircraft, including helicopters and fixed-wing planes, with the same controls. FlightOS aims to enhance flight safety and streamline piloting by significantly reducing pilot fatigue and complexity, making it accessible for pilots to operate different aircraft configurations after minimal training. Skyryse serves various sectors, including emergency services, public transport, and urban planning, positioning itself as a leader in advancing general aviation technology.

Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

Shockwave Medical, Inc. is a medical device company that specializes in intravascular lithotripsy technology aimed at treating calcified plaque in patients with various cardiovascular diseases. The company has developed the Lithoplasty™ family of balloon dilatation catheters, which incorporate lithotripsy electrodes to enhance the compliance of rigid vascular and valvular lesions before low-pressure dilation. This approach minimizes injury to healthy tissue and addresses limitations associated with traditional revascularization technologies. Shockwave offers specific catheters for different applications, including M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. The technology is designed to facilitate more effective angioplasty and improve stent delivery, as well as enhance native tissue preparation for trans-catheter aortic valve replacement. Founded in 2009 and headquartered in Santa Clara, California, Shockwave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists across the United States and internationally.

Numerated Growth Technologies, Inc. is a Boston-based company founded in 2015 that specializes in developing a real-time sales platform for business and retail banking. The company's digital lending and sales platform simplifies the process for businesses to access financial products from banks by enabling seamless digital applications, account openings, and lending experiences. Numerated enhances these services through rich data integrations, credit pre-screening, and core data analysis tools, which assist banks in executing more targeted sales and marketing campaigns. The platform is utilized by several prominent business banks, including Bremer Bank, Dollar Bank, and Eastern Bank, among others.

Shape provides defense against malicious automated cyber-attacks on web and mobile applications. Shape has deflected over $1B in fraud losses for major retailers, financial institutions, airlines, and government agencies. Shape Security is headquartered in Silicon Valley and backed by Kleiner Perkins Caufield & Byers, Norwest Venture Partners, Venrock, Baseline Ventures, Google Ventures, WING VC and a host of other prominent investors. Shape was founded in 2011 to disrupt automated attacks on web and mobile applications.

Dapper Labs Inc., based in Vancouver, Canada, is a developer of blockchain-based video games and digital collectibles. Founded in 2018, the company is known for its consumer-focused Flow blockchain platform, which supports the creation and distribution of non-fungible tokens (NFTs) and other digital assets. Dapper Labs aims to enhance digital engagement by allowing fans to interact with their favorite brands in innovative ways. Through its platform, users can securely track ownership of unique digital items while also having the opportunity to create their own content. This approach not only entertains but also fosters a decentralized environment where value is placed on digital collectibles and user-generated creations.

Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technology to enable a simplified experience, and by partnering with top providers for better health outcomes.

CTERA Networks Ltd. specializes in providing a private cloud storage platform that enables organizations to manage their data securely and efficiently. Founded in 2008 and headquartered in Petah Tikvah, Israel, the company offers a range of services including branch storage modernization, endpoint backup, cloud transformation, and ransomware recovery. Its Enterprise File Services Platform allows enterprises to store, sync, share, protect, and govern data across various endpoints and remote offices. CTERA's solutions, such as the CTERA Edge Filer and CTERA Drive, facilitate secure file access and collaboration, catering to industries like financial services, healthcare, and media. The company has established strategic partnerships with prominent technology firms, enhancing its service offerings. CTERA is recognized for its role in enabling modern remote work environments and is trusted by Fortune 100 companies and leading service providers worldwide.

Atom Computing Inc. is a company based in Berkeley, California, that focuses on manufacturing scalable quantum computers utilizing individual atoms. Founded in 2018, the company harnesses the quantum mechanical properties of atoms to process information and address complex problems that traditional computers cannot solve. Atom Computing's technology allows for the optical control, scaling, and stabilization of these atoms, facilitating efficient quantum calculations in various fields, including drug design, computational chemistry, and general computing. Through its innovative approach, Atom Computing aims to advance the development of quantum technology and expand its applications across multiple industries.

Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. Operating in the United Kingdom, European Union, and the United States, Orchard employs an autologous ex vivo gene therapy approach to transform patients’ hematopoietic stem cells into gene-modified products for treatment through a single administration. Its portfolio includes Strimvelis, the first approved gene therapy for adenosine deaminase-severe combined immunodeficiency (ADA-SCID), along with several products in clinical development targeting metachromatic leukodystrophy, Wiskott-Aldrich syndrome, X-linked chronic granulomatous disease, and transfusion-dependent beta-thalassemia. The company also has a robust preclinical pipeline addressing various mucopolysaccharidosis types. Orchard collaborates with leading institutions in gene therapy, enhancing its research capabilities and clinical programs. Founded in 2015, Orchard Therapeutics continues to demonstrate a commitment to transforming the lives of patients through its advanced therapies.